The National Cancer Control Programme (NCCP) hosted a Urological Cancer Quality and Audit Forum on 10 November 2023.
Speaking about the Forum, Ms Fiona Bonas, Assistant National Director, NCCP stated:
“She was delighted to open the NCCP Urological Cancer Quality and Audit Forum. The Forum this year celebrates over a decade of National Network of Rapid Access Prostate Cancer Clinics (RAPC), and how they have improved prostate cancer outcomes in the Republic of Ireland”
Mr Paul Sweeney, National Clinical Lead for Urological Cancers, Consultant Urologist, and Mercy University Hospital stated that:
“He was delighted to welcome national multi-disciplinary urological cancer teams who attended. It was an opportunity to build on local clinical governance arrangements, and develop cohesive national clinical networks for the purpose of clinical audit, sharing of good practice and problem solving.”
Ms Eileen Nolan, Programme Manager, and NCCP, concluded: “We would like to thank everyone involved in the NCCP Urological Cancer Programme for their invaluable contribution.”
The guest speaker was Prof Hendrik Van Poppel, Co-Chair, Inequalities Network, European Cancer Organisation, Chairman of the Department of Urology at the University Hospital Gasthuisberg, Katholieke Universiteit (KU) Leuven, Belgium. His presentation focused on Prostate Cancer Screening (Why and How), and referred to the Prostate Cancer Screening Pilot taking place in Ireland as part of the PRAISE-U European Study. https://www.europeancancer.org/eu-projects/resource/praise-u
The purpose of the forum is to provide an annual multidisciplinary forum for quality and audit for Urological Cancer Services. It helps identify best practice models and ensure standardisation and service improvement nationally.
The participants include members of the urological cancer services multidisciplinary team: surgery, radiology, pathology, medical oncology, microbiology, nursing and data management.
A series of workshops took place, which facilitated problem solving, and sharing of best practice models.
Key Achievements:
Expansion of NCCP Urological Cancer Clinical Leads Group:
- Clinical Leads Group now includes; prostate, bladder, kidney, testicular and penile cancers
Prostate:
Penile Cancer:
- Development of a National Penile Cancer Clinical Lead at Beaumont Hospital
Bladder/Kidney Cancers
- Implementation and rollout of national haematuria pathway with NPCS
- Development of the roles of Advanced Nurse Practitioners (ANP), Clinical Nurse Specialists, and patient navigators
- Focus on developing bladder cancer services for better patient outcomes
Testis Cancers
- Plans to develop a national testis cancer multi-disciplinary meeting.
Last updated on: 07 / 12 / 2023
